Burlington's CMO sold 1,678 shares at $369.04 under a March 2026 10b5-1 plan. She retains $28.6M in stock. The off-price retailer is gaining market share.
Jennifer Vecchio, group president and chief marketing officer of Burlington Stores, sold 1,678 shares of common stock on Aug. 3, 2026, according to a Form 4 filing with the SEC. The transaction was executed at a weighted average price of $369.04 per share, valuing the sale at roughly $620,000.
The sale was carried out under a Rule 10b5-1 trading plan adopted in March 2026, the filing said. That means the timing and size of the trade were set months ahead of the transaction, likely for personal liquidity or estate planning rather than in response to recent price moves or business developments.
Vecchio still holds 77,661 shares directly after the sale, a 2% reduction from her prior position. Those shares were worth $28.6 million at the Aug. 3 close of $368.23.
The transaction comes as Burlington, an off-price retailer with a $23.2 billion market capitalization, has seen its operating margins rebound to 7.4%, a multi-year high after a sharp drop in 2022. The company has also been gaining market share against peers like TJX Companies and Ross Stores, according to a Motley Fool analysis of the company's recent performance.
Burlington's stock has delivered a total return of 9% since 2021. The S&P 500 returned 87% over the same stretch. Much of that underperformance was concentrated in 2021 and 2022. Since 2023, Burlington shares have outperformed the broader index. The company generated $11.9 billion in trailing 12-month revenue. Its one-year share price appreciation stands at roughly 35%.
AlphaScala's proprietary score for Burlington is 54 out of 100, labeled Mixed, reflecting the mixed signals from insider activity and the company's operational trajectory. The stock page is available at BURL stock page.
For investors, the key question is whether Vecchio's sale signals anything about the company's outlook. The 10b5-1 plan weakens the signal considerably. Insiders sell for many reasons unrelated to business health: tax withholding, diversification, or planned liquidity. The remaining stake of $28.6 million suggests confidence in the company's long-term prospects.
What would make the risk more serious? If other executives or directors begin selling sizable chunks without prearranged plans, or if the company's operating margins reverse course. For now, the single sale under a scheduled plan does not change the fundamental picture.
Burlington's next quarterly results are expected in late August. The stock closed at $368.23 on Aug. 3, the day of the transaction.
Drafted by a large language model from the source reporting linked above, then screened by automated publishing checks. It is not read by a journalist before publication. Some articles cite our Alpha Score. Verify prices and figures against the original source. Educational coverage, not personalized advice.